Published in
Elsevier, Gynecologic Oncology, 2(137), p. 216-222, 2015
DOI: 10.1016/j.ygyno.2015.03.005
Links
Tools
A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia
Journal article published in 2015 by
Ivan Diaz-Padilla,
Michelle K. Wilson,
Blaise A. Clarke,
Hal W. Hirte,
Stephen A. Welch,
Helen J. Mackay,
Jim J. Biagi,
Michael Reedijk,
Johanne I. Weberpals,
Gini F. Fleming,
Lisa Wang,
Geoffrey Liu,
Chen Zhou,
Chantale Blattler,
S. Percy Ivy 
and other authors.
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 